Targeting AMPK by statins: a potential therapeutic approach

S Dehnavi, A Kiani, M Sadeghi, AF Biregani, M Banach… - Drugs, 2021 - Springer
Statins are a group of lipid-lowering drugs that inhibit cholesterol biosynthesis and have anti-
inflammatory, anti-tumor, and immunomodulatory properties. Several lines of evidence …

Antitumor and hepatoprotective activity of natural and synthetic neo steroids

VM Dembitsky - Progress in lipid research, 2020 - Elsevier
In this review, steroids with a tertiary butyl group, which are usually called neo steroids, are a
small group of natural lipids isolated from higher plants, fungi, marine sponges, and yeast. In …

Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition

A Emami, S Shojaei, SC da Silva Rosa… - European Journal of …, 2019 - Elsevier
Statins are some of the most widely used drugs worldwide, but one of their major side effects
is myotoxicity. Using mouse myoblast (C2C12) and human alveolar rhabdomyosarcoma cell …

Statins and autoimmunity: State-of-the-art

S Dehnavi, N Sohrabi, M Sadeghi, P Lansberg… - Pharmacology & …, 2020 - Elsevier
HMG-CoA reductase inhibitors, or statins, are potent plasma LDL-cholesterol (LDL-c)
lowering agents. Since the introduction of the first statin, lovastatin, in 1987, accumulating …

[HTML][HTML] Mechanisms of induction of tumors by cholesterol and potential therapeutic prospects

Y Xi, Z Yani, M Jing, W Yinhang, H Xiaohui… - Biomedicine & …, 2021 - Elsevier
Increasing evidence suggested that cholesterol is an important integrant of cell membranes,
that plays a key role in tumor progression, immune dysregulation, and pathological changes …

Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas

E de Groot, S Varghese, L Tan, B Knighton… - Cancer & …, 2022 - Springer
Background Primary and posttreatment resistance to BRAFV600 mutation–targeting
inhibitors leads to disease relapse in a majority of melanoma patients. In many instances …

Simvastatin suppresses human breast cancer cell invasion by decreasing the expression of pituitary tumor-transforming gene 1

L Yin, Z He, B Yi, L Xue, J Sun - Frontiers in pharmacology, 2020 - frontiersin.org
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, have been widely
used to lower cholesterol and prevent cardiovascular diseases. Recent preclinical and …

On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells

G Ntolkeras, C Barba, A Mavropoulos… - Immunologic …, 2019 - Springer
Statins, the cholesterol-lowering drugs, also possess immunomodulatory properties,
affecting among others T cell activation and differentiation, antigen presentation, and …

Characterization of feedback-resistant mevalonate kinases from the methanogenic archaeons Methanosaeta concilii and Methanocella paludicola

E Kazieva, Y Yamamoto, Y Tajima… - …, 2017 - microbiologyresearch.org
The inhibition of mevalonate kinase (MVK) by downstream metabolites is an important
mechanism in the regulation of isoprenoid production in a broad range of organisms. The …

Quo vadis PGRMC? Grand-scale biology in human health and disease

MA Cahill - Frontiers in Bioscience-Landmark, 2022 - researchoutput.csu.edu.au
The title usage of Latin Quo vadis 'where are you going'extends the question Unde venisti
from where 'did you come?'posed in the accompanying paper and extends consideration of …